Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLCverified

DCHPF

Price:

$46.9

Market Cap:

$4.40B

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, su...[Read more]

Industry

Medical - Pharmaceuticals

IPO Date

2016-07-11

Stock Exchange

OTC

Ticker

DCHPF

The Enterprise Value as of November 2025 (TTM) for Dechra Pharmaceuticals PLC (DCHPF) is 4.83B

According to Dechra Pharmaceuticals PLC’s latest financial reports and current stock price. The company's current Enterprise Value is 4.83B. This represents a change of 7.79% compared to the average of 4.48B of the last 4 quarters.

Dechra Pharmaceuticals PLC (DCHPF) Historical Enterprise Value (quarterly & annually)

How has DCHPF Enterprise Value performed in the past?

The mean historical Enterprise Value of Dechra Pharmaceuticals PLC over the last ten years is 2.69B. The current 4.83B Enterprise Value has changed 17.89% with respect to the historical average. Over the past ten years (40 quarters), DCHPF's Enterprise Value was at its highest in in the December 2021 quarter at 5.99B. The Enterprise Value was at its lowest in in the December 2003 quarter at 74.95M.

Quarterly (TTM)
Annual

Average

2.69B

Median

2.98B

Minimum

637.23M

Maximum

4.93B

Dechra Pharmaceuticals PLC (DCHPF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Dechra Pharmaceuticals PLC Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 71.04%

Maximum Annual Enterprise Value = 4.93B

Minimum Annual Increase = -19.71%

Minimum Annual Enterprise Value = 637.23M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20234.61B16.65%
20223.95B-19.71%
20214.93B60.80%
20203.06B0.39%
20193.05B4.90%
20182.91B71.04%
20171.70B46.06%
20161.16B36.87%
2015850.54M33.48%
2014637.23M-8.95%

Dechra Pharmaceuticals PLC (DCHPF) Average Enterprise Value

How has DCHPF Enterprise Value performed in the past?

The current Enterprise Value of Dechra Pharmaceuticals PLC (DCHPF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

4.50B

5-year avg

3.92B

10-year avg

2.69B

Dechra Pharmaceuticals PLC (DCHPF) Enterprise Value vs. Peers

How is DCHPF’s Enterprise Value compared to its peers?

Dechra Pharmaceuticals PLC’s Enterprise Value is greater than McKesson Europe AG (4.78B), greater than Abcam plc (134.60M), less than Hangzhou Tigermed Consulting Co., Ltd. (36.59B), less than Sugi Holdings Co.,Ltd. (606.93B), less than Mediclinic International plc (392.29B), less than Galenica AG (5.37B), less than Ascentage Pharma Group International (21.50B), greater than Indivior PLC (3.93B), greater than Indivior PLC (3.93B), less than Nihon Kohden Corporation (250.32B),

Build a custom stock screener for Dechra Pharmaceuticals PLC (DCHPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dechra Pharmaceuticals PLC using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Dechra Pharmaceuticals PLC (DCHPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Dechra Pharmaceuticals PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Dechra Pharmaceuticals PLC's Enterprise Value?

What is the highest Enterprise Value for Dechra Pharmaceuticals PLC (DCHPF)?

What is the 3-year average Enterprise Value for Dechra Pharmaceuticals PLC (DCHPF)?

What is the 5-year average Enterprise Value for Dechra Pharmaceuticals PLC (DCHPF)?

How does the current Enterprise Value for Dechra Pharmaceuticals PLC (DCHPF) compare to its historical average?